Evidence map›Paper›PMID 35736414›Full record

ArticleMetabolites2022

Direct In Vivo Analysis of CBD- and THC-Acid Cannabinoids and Classification of Cannabis Cultivars Using SpiderMass.

Nina Ogrinc, Serge Schneider, Adèle Bourmaud, Nicolas Gengler, Michel Salzet, Isabelle Fournier

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nina OgrincLaboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Inserm U1192, Université de Lille, F-59000 Lille, France.
Serge SchneiderService de Toxicologie Analytique-Chimie Pharmaceutique, Laboratoire National de Santé (LNS), Dudelange, L-3555 Luxembourg, Luxembourg.ORCID 0000-0003-0485-8269
Adèle BourmaudService de Toxicologie Analytique-Chimie Pharmaceutique, Laboratoire National de Santé (LNS), Dudelange, L-3555 Luxembourg, Luxembourg.ORCID 0000-0002-0557-3639
Nicolas GenglerService de Toxicologie Analytique-Chimie Pharmaceutique, Laboratoire National de Santé (LNS), Dudelange, L-3555 Luxembourg, Luxembourg.
Michel SalzetLaboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Inserm U1192, Université de Lille, F-59000 Lille, France.
Isabelle FournierLaboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Inserm U1192, Université de Lille, F-59000 Lille, France.ORCID 0000-0003-1096-5044

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, cannabis and hemp-based products have become increasingly popular for recreational use, edibles, beverages, health care products, and medicines. The rapid detection and differentiation of phytocannabinoids is, therefore, essential to assess the potency and the therapeutic and nutritional values of cannabis cultivars. Here, we implemented SpiderMass technology for in vivo detection of cannabidiolic acid (CBDA) and ∆

Indexed as

cannabinoidsin vivomass spectrometryplantsSpiderMasswater-assisted laser desorption/ionization

Identifiers

PMID35736414
PMCPMC9227750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.